PNGC would like to congratulate Edward Lee, MD, Ph.D., Associate Professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania and a practicing neuropathologist in the Division of Neuropathology on earning tenure! Dr. Lee has been at Penn since 1997, where he did his MD/Ph.D. from 1997 to […]
The National Institute on Aging (NIA) recently announced a new resource that will help teach and assist those whose lives are affected by Alzheimer’s disease and related dementias. Alzheimers.gov is a website that serves as the federal government portal for dementia information and resources. To create Alzheimers.gov, the NIA worked with individuals living with dementia, […]
Join leading scientists, patient advocacy groups, and government members April 19-22 for the 2021 NIH Alzheimer’s Research Summit to showcase Alzheimer’s disease research developments. The virtual summit’s agenda and registration are now available and can be accessed via the NIA Summit website.
University of Pennsylvania senior and PNGC undergraduate researcher Lauren Kleidermacher was awarded the Thouron Award to pursue her graduate studies in the United Kingdom. The award was established in 1960 by John Thouron and his wife, Esther du Pont Thouron, to promote closer ties between the U.K. and the United States. The award covers full […]
On October 27-30, ASHG members and leading scientists worldwide presented their research findings to the American Society of Human Genetics (ASHG) 2020 Virtual Meeting. Among them were several Penn Neurodegeneration Genomics Center (PNGC) members who had the opportunity to learn from and share their latest updates with the genetics and genomics research community. Pavel Kuksa, […]
A team of researchers led by Li-San Wang, PhD, Professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at the University of Pennsylvania, has been awarded a two-year pilot grant expected to total $4.8 million from the National Institute on Aging (NIA) to study the genetics of Alzheimer’s disease in people of […]
Alzheimer’s disease (AD) is one of the most serious public health challenges that affect the nation. Both the direct and indirect costs of AD have been stressing the healthcare system. The cause of AD, however, is still unknown. The recent development of genome-wide association studies (GWASs) has been a powerful tool for discovering thousands of […]